Driehaus Capital Management LLC Bristol Myers Squibb CO Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $57,364 - $65,064	873 Added 30.5%	3,735 $258,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $195,989 - $232,079	2,862 New	2,862 $205,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $290,825 - $322,272	-5,064 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $4,440 - $5,191	81 Added 1.63%	5,064 $298,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $56,840 - $82,601	1,225 Added 32.6%	4,983 $278,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $184,931 - $241,226	3,758 New	3,758 $241,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.